SMART

Serial Number 97041678
730

Registration Progress

Application Filed
Sep 23, 2021
Under Examination
Apr 29, 2025
Approved for Publication
Mar 4, 2025
Published for Opposition
Mar 4, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 29, 2026 95 days

Trademark Image

SMART

Basic Information

Serial Number
97041678
Filing Date
September 23, 2021
Published for Opposition
March 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Oct 28, 2025
Application
Pending
Classes
005 042

Rights Holder

Entrada Therapeutics, Inc.

03
Address
One Design Center Pl, Suite 17-500
Boston, MA 02210

Ownership History

Entrada Therapeutics, Inc.

Original Applicant
03
Boston, MA

Entrada Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Stephanie H. Bald

USPTO Deadlines

Next Deadline
95 days remaining
NOA E-Mailed - SOU Required
Due Date
April 29, 2026
Extension Available
Until October 29, 2026

Application History

29 events
Date Code Type Description Documents
Oct 29, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 28, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 28, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 28, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 29, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 9, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 21, 2024 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Mar 8, 2024 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Sep 6, 2023 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Jul 24, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 24, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 24, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 24, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 24, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 11, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 11, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Feb 11, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Dec 1, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 30, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 30, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 2, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 2, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 2, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 25, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 25, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 27, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for human use for the treatment of diseases, namely, pharmaceutical preparations for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes
Class 042
Pharmaceutical research and development services

Classification

International Classes
005 042